|
🐜
|
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics
22 auth.
G. Bertsias,
J. Ioannidis,
J. Boletis,
S. Bombardieri,
R. Cervera,
C. Dostál,
J. Font,
I. Gilboe,
F. Houssiau,
T. Huizinga,
...
D. Isenberg,
C. Kallenberg,
M. Khamashta,
J. Piette,
M. Schneider,
M. Schneider,
J. Smolen,
G. Sturfelt,
A. Tincani,
R. Vollenhoven,
C. Gordon,
D. Boumpas
|
9 |
2007 |
9
🐜
|
|
🐜
|
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs
26 auth.
G. Bertsias,
J. Ioannidis,
M. Aringer,
E. Bollen,
S. Bombardieri,
I. Bruce,
R. Cervera,
M. Dalakas,
A. Doria,
J. Hanly,
T. Huizinga,
D. Isenberg,
C. Kallenberg,
J. Piette,
M. Schneider,
...
N. Scolding,
J. Smolen,
A. Stara,
I. Tassiulas,
M. Tektonidou,
A. Tincani,
M. Buchem,
R. Vollenhoven,
M. Ward,
C. Gordon,
D. Boumpas
|
9 |
2010 |
9
🐜
|
|
🐜
|
Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review.
8 auth.
B. D. Lange-Brokaar,
A. Ioan-Facsinay,
G. Osch,
A. Zuurmond,
J. Schoones,
R. Toes,
...
T. Huizinga,
M. Kloppenburg
|
9 |
2012 |
9
🐜
|
|
🐬
|
Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis.
J. Wessels,
T. Huizinga,
H. Guchelaar
|
8 |
2007 |
8
🐬
|
|
🐜
|
Cytokine gene polymorphism in human disease: on-line databases, Supplement 1
11 auth.
J. Bidwell,
L. Keen,
G. Gallagher,
R. Kimberly,
T. Huizinga,
Michael F. McDermott,
...
J. Oksenberg,
J. Mcnicholl,
F. Pociot,
C. Hardt,
S. D'alfonso
|
8 |
2001 |
8
🐜
|
|
🐜
|
Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways.
8 auth.
L. Trouw,
E. M. Haisma,
E. Levarht,
D. Woude,
A. Ioan-Facsinay,
M. Daha,
...
T. Huizinga,
R. Toes
|
7 |
2009 |
7
🐜
|
|
🐜
|
Cytokine gene polymorphism in human disease: on-line databases, Supplement 2
13 auth.
N. Haukim,
J. Bidwell,
A. Smith,
L. Keen,
G. Gallagher,
R. Kimberly,
T. Huizinga,
Michael F. McDermott,
J. Oksenberg,
J. Mcnicholl,
...
F. Pociot,
C. Hardt,
S. D'alfonso
|
7 |
2002 |
7
🐜
|
|
🐜
|
Tumour necrosis factor alpha gene polymorphisms in rheumatoid arthritis: association with susceptibility to, or severity of, disease?
8 auth.
B. Brinkman,
T. Huizinga,
S. Kurban,
E. A. Velde,
G. Schreuder,
J. Hazes,
...
F. Breedveld,
C. Verweij
|
7 |
1997 |
7
🐜
|
|
🐬
|
Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus
J. Eskdale,
V. Keijsers,
T. Huizinga,
G. Gallagher
|
7 |
1999 |
7
🐬
|
|
🐢
|
TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus.
12 auth.
M. Rood,
M. V. Krugten,
E. Zanelli,
M. V. D. Linden,
V. Keijsers,
G. Schreuder,
...
W. Verduyn,
R. Westendorp,
R. D. Vries,
F. Breedveld,
C. Verweij,
T. Huizinga
|
7 |
2000 |
7
🐢
|
|
🐜
|
MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis
9 auth.
I. Tchetverikov,
H. Ronday,
B. V. El,
G. Kiers,
N. Verzijl,
J. Tekoppele,
...
T. Huizinga,
Jeroen DeGroot,
Roeland Hanemaaijer
|
7 |
2004 |
7
🐜
|
|
🐜
|
Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus
11 auth.
I. Hoffman,
B. Lauwerys,
F. Keyser,
T. Huizinga,
D. Isenberg,
L. Cebecauer,
...
J. Dehoorne,
R. Joos,
G. Hendrickx,
F. Houssiau,
D. Elewaut
|
7 |
2008 |
7
🐜
|
